Dr. Venkatesan most recently served as Chairman, President, and CEO of Angion Biomedica until its merger with Elicio Therapeutics in 2023. He currently serves as a Board Director at Elicio ...

Ajibola Joshua Ajayi, CFA, has been standing at the forefront of sustainable investment, energy finance, and strategic capital allocation. With ...

Rep. Mark White, a Republican from Memphis, said state intervention is coming for MSCS. Research suggests it's more harmful ...

Two Chinese state-owned automakers, Dongfeng Motor Group and Chongqing Changan Automobile Company, are understood to be ...

We found that most boards default to a single engagement style, which limits their effectiveness. For instance, a passive ...

S&P has been able to leverage its moat to obtain solid pricing power, typically around 3%-4% per year. In 2024, S&P's rack rate for corporate finance ratings was 7.90 basis points, compared with 6.25 ...

"Collectively Juan, Faiz and Matt represent a meaningful step toward rapidly building out our Financial Institutions practice ...

Recent studies suggest a majority of mergers fail. Two tenured professors identified the potential pitfalls and keys to ...

Union Health announced Tuesday that it has submitted a new 2025 Certificate of Public Advantage (COPA) application to acquire ...

Sacramento college preparatory services company Guidewell Education has raised a $43 million growth investment from New ...

From climate change to geopolitics and artificial intelligence, there are many factors they must take into account while ...

Morphosis Capital Partners BV announced the official launch of Morphosis Capital Fund II, its second investment fund, with a ...